Rat-derived recombinant CALB1 (e.g., PROTP07171 from Boster Bio) is widely used in experimental studies:
Immunohistochemistry (IHC): Adsorption control for antibody validation. For example, 1 µg of recombinant CALB1 neutralizes monoclonal antibodies in IHC protocols .
UVB Radiation Studies: Investigates CALB1’s role in reducing apoptosis in human lens epithelial cells (HLECs) under UVB stress .
Aging Research: Quantifies age-dependent CALB1 decline in rat lenses (12–18 months vs. 1–6 months) .
Protective Role: siRNA knockdown of Calb1 in rat lens epithelial cells increased UVB-induced apoptosis by 35–40%. This correlated with upregulated pro-apoptotic protein Bad and downregulated anti-apoptotic Bcl-2 .
Mechanism: CALB1 buffers intracellular Ca²⁺ surges, preventing mitochondrial dysfunction and caspase activation .
Lens Epithelium: CALB1 protein levels dropped by 50% in 12–18-month-old rats compared to younger cohorts. mRNA levels decreased similarly, independent of epithelial cell density .
Implications: Reduced CALB1 may contribute to age-related cataracts due to impaired Ca²⁺ regulation .
Commercial antibodies enable precise detection in research:
Antibody | Host | Clone | Applications | Reactivity |
---|---|---|---|---|
MA1007 | Mouse | CB-955 | WB, IHC, RIA | Human, Mouse, Rat |
75-448 | Mouse | L109/57 | ICC, IHC, WB | Human, Mouse, Rat |
Both antibodies show no cross-reactivity with other proteins and target the 28 kDa CALB1 band .
Gene Ontology: Calb1 is implicated in synaptic plasticity, cochlea development, and response to auditory stimuli .
Disease Links: Associated with neurodegenerative diseases (e.g., Alzheimer’s) due to its role in neuronal Ca²⁺ buffering .
Example Adsorption Protocol for IHC1:
Dilute anti-CALB1 antibody 1:5,000 in buffer.
Add 1 µg recombinant CALB1 per 1 mL diluted antibody.
Incubate at 4°C for ≥6 hours.
Apply to tissue sections for 3 days.
Complete staining with biotinylated secondary antibody and DAB.
CALB1 is widely distributed across multiple rat tissues with varying expression levels. The protein belongs to the EF-hand Ca²⁺ binding protein family and has a molecular weight of approximately 28 kDa . Research has documented significant CALB1 expression in the rat brain (particularly cerebellum), pancreas, bone tissue, and nervous system . Notably, CALB1 is also expressed in the lens of Sprague-Dawley (SD) rats, where it is distributed in both epithelial and fiber cells .
When designing experiments investigating CALB1 distribution, researchers should account for age-related variations, as CALB1 levels have been shown to decline significantly with increasing age in the rat lens, without a corresponding decrease in lens cell numbers . This age-related reduction reflects a genuine decrease in gene expression within these cells rather than cell loss, suggesting important implications for age-related lens pathologies.
CALB1 primarily functions as an intracellular calcium buffer that helps maintain calcium homeostasis by buffering excessive intracellular free Ca²⁺ . In rat lens epithelial cells, CALB1 plays a crucial role in reducing and stabilizing intracellular Ca²⁺ levels when calcium concentrations increase . This regulatory function is particularly important since aberrant Ca²⁺ homeostasis is implicated in various pathological conditions.
When designing experiments to study CALB1's calcium buffering capacity, researchers should consider using techniques such as calcium imaging with fluorescent indicators in combination with CALB1 manipulation (overexpression or knockdown). Studies have shown that reduced CALB1 expression may lead to increased intracellular free Ca²⁺ concentrations, which are observed in several age-related diseases . Methodologically, it's important to establish appropriate controls and standardize calcium measurement techniques when comparing different experimental conditions.
For accurate quantification of CALB1 in rat tissues, a multi-method approach is recommended:
Protein quantification: Western blot analysis with specific anti-CALB1 antibodies provides reliable quantification of protein levels, as demonstrated in studies of rat lens tissue .
Gene expression analysis: Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) effectively measures Calb1 mRNA expression levels, validating protein-level findings .
Tissue distribution: Immunohistochemistry allows visualization of CALB1 distribution across different cell types within a tissue, particularly useful for heterogeneous tissues like the lens or brain regions .
When implementing these methods, researchers should include age-matched controls, as CALB1 expression shows significant age-related changes. For instance, studies in SD rat lenses have demonstrated declining CALB1 levels with increasing age (1, 6, 12, and 18 months), with corresponding reductions in mRNA expression .
Genetic manipulation of CALB1 produces complex effects on stress susceptibility and behavior, with important implications for psychiatric research. While most studies have been conducted in mice, the findings provide valuable insights for rat research.
In stress studies, CALB1 knockdown in the ventral hippocampus has been shown to increase resilience to social defeat stress . Specifically, knockdown of CALB1 in this region abolished stress-induced increases in ventral hippocampal sharp wave ripples and prevented social interaction deficits . This suggests a critical role for CALB1 in mediating stress responses through hippocampal circuit activity.
For behavioral phenotyping following CALB1 manipulation, researchers should employ a comprehensive battery of tests examining multiple domains:
Anxiety assessment: Elevated plus maze testing shows that CALB1 knockout animals display significantly decreased anxiety-like behavior .
Fear conditioning: CALB1 knockout male mice show altered fear memory acquisition and recall .
Social behavior evaluation: Tests measuring social preference and interaction time reveal that male CALB1 knockouts spend more time interacting with stimulus animals than controls .
When designing such experiments in rats, researchers should carefully consider sex differences, as CALB1 knockout produces sex-specific effects on behavior and gene expression in the prefrontal cortex and amygdala .
CALB1 exerts neuroprotective effects through multiple molecular mechanisms that researchers can investigate:
Calcium homeostasis regulation: CALB1 buffers excessive intracellular calcium, preventing calcium-mediated excitotoxicity and cell death . Experimental approaches should measure intracellular calcium dynamics in neurons with varying CALB1 expression levels.
Modulation of gene expression: CALB1 knockout alters expression of genes related to brain-derived neurotrophic factor (BDNF) signaling, hormone receptors, histone deacetylases, and GABA signaling in the amygdala and prefrontal cortex . RNA sequencing or targeted gene expression analyses can identify downstream molecular pathways.
Stress hormone signaling: CALB1 knockout mice show altered expression of corticotropin-releasing hormone receptor 1 (CRHR1) in the amygdala, which may explain changes in fear and anxiety-like behaviors . Experimental designs should incorporate measures of HPA axis function and stress hormone levels.
Researchers investigating these mechanisms should employ both in vitro and in vivo approaches, with careful attention to regional specificity since CALB1's effects may vary across brain regions. Interestingly, despite changes in CRHR1 expression, baseline and post-stress corticosterone levels were not significantly different between CALB1 knockout and wild-type mice , suggesting complex regulatory mechanisms beyond simple HPA axis alterations.
Contradictory findings regarding CALB1 function across rat strains likely stem from several factors that researchers should systematically address:
To reconcile contradictory findings, researchers should design comprehensive studies with clearly defined variables, including strain, age, sex, and specific brain regions or tissues of interest.
Several techniques have proven effective for manipulating CALB1 expression in rat models, each with specific advantages:
Viral vector-mediated approaches:
Short hairpin RNA (shRNA) delivered via adeno-associated virus (AAV) vectors effectively knocks down CALB1 expression in specific brain regions .
For overexpression studies, AAV vectors carrying the Calb1 gene can be used for region-specific enhancement .
Advantage: Allows for spatially and temporally controlled manipulation in adult animals.
Lentiviral transfection:
CRISPR-Cas9 genome editing:
While not specifically mentioned in the search results, CRISPR-Cas9 technology offers precise genetic manipulation of Calb1 in rats.
This approach allows for complete knockout or specific mutations.
Advantage: Creates permanent genetic modifications that can be bred to establish knockout lines.
When implementing these techniques, researchers should verify manipulation efficacy through multiple methods, including qPCR for mRNA levels, western blot for protein expression, and immunohistochemistry for spatial distribution . Control vectors (e.g., scrambled shRNA) should be used to account for non-specific effects of the viral delivery method .
To effectively study age-related changes in CALB1 expression, researchers should implement longitudinal or cross-sectional designs with the following methodological considerations:
Cross-sectional age comparisons:
Tissue-specific sampling protocols:
For lens tissue: Isolate whole lenses and process for both immunohistochemistry and protein/RNA extraction .
For brain tissue: Use microdissection techniques to isolate specific regions (e.g., hippocampus, prefrontal cortex, amygdala) where CALB1 shows distinct functions .
Advantage: Allows for region-specific analysis of age-related changes.
Correlative functional assessments:
Pair expression analyses with functional measures relevant to the tissue being studied.
For lens: Measure calcium levels and assess lens transparency/cataract formation .
For brain: Conduct behavioral tests appropriate to the regions being studied (e.g., hippocampal-dependent learning tasks) .
Advantage: Links expression changes to functional outcomes.
The experimental design should control for potential confounding variables such as housing conditions, diet, and environmental enrichment, which might independently affect CALB1 expression or the functional outcomes being measured.
CALB1 exhibits distinct functions in rat lens compared to neural tissues, which researchers should consider when designing tissue-specific studies:
In rat lens:
CALB1 functions primarily as a calcium buffer to prevent calcium-induced oxidative damage and maintain lens transparency .
CALB1 expression in lens epithelial and fiber cells decreases significantly with age, which may contribute to age-related lens pathologies like cataracts .
The protective role of CALB1 in lens cells involves preventing apoptosis induced by stressors such as UVB radiation .
In neural tissues:
Beyond calcium buffering, CALB1 modulates neuronal excitability and synaptic plasticity .
In the hippocampus, CALB1 regulates sharp wave ripples and affects stress susceptibility .
CALB1 influences the expression of genes related to BDNF signaling, hormone receptors, histone deacetylases, and GABA signaling in the amygdala and prefrontal cortex .
When studying these tissue-specific differences, researchers should employ tissue-appropriate methodologies:
For lens studies: Focus on calcium imaging, cell survival assays, and lens transparency measurements .
For neural tissue studies: Include electrophysiological recordings, behavioral assessments, and pathway-specific molecular analyses .
These distinct functions suggest that therapeutic approaches targeting CALB1 would need to be tissue-specific, with different strategies for lens protection versus neuropsychiatric applications.
CALB1 plays a critical role in hippocampal sharp wave ripples (SWRs) and stress resilience in rodents, with important implications for psychiatric research:
Regulation of SWR activity:
Susceptible animals show increased ventral hippocampal SWR rates following social defeat stress compared to resilient animals .
CALB1 knockdown in the ventral hippocampus prevents this stress-induced increase in SWR activity .
This suggests CALB1 is a key modulator of hippocampal network activity in response to stress.
Mediating stress susceptibility:
CALB1 expression levels are enhanced in stress-susceptible mice compared to resilient mice .
Ventral hippocampus-specific knockdown of CALB1 significantly increases resilience to social defeat stress .
This demonstrates that CALB1 expression in the ventral hippocampus contributes to a pro-susceptibility phenotype.
Experimental approaches to study this relationship:
Combine genetic manipulation (e.g., shRNA knockdown) with in vivo electrophysiological recordings of SWRs .
Pair these with behavioral assessments of stress resilience (e.g., social interaction tests following social defeat) .
Use calcium imaging to determine how CALB1 modulation affects calcium dynamics in hippocampal neurons during stress.
Interestingly, while CALB1 knockdown increased stress resilience, overexpression of CALB1 in the ventral hippocampus did not significantly affect stress-induced social interaction deficits . This asymmetric effect suggests that endogenous CALB1 levels may already be optimized for susceptibility effects, and researchers should consider this when designing gain-of-function versus loss-of-function experiments.
CALB1 has significant implications for age-related pathologies in rat models, particularly in lens and neural tissues:
Lens pathology and cataract formation:
CALB1 expression in rat lens decreases significantly with age .
This reduction is associated with increased intracellular calcium accumulation, a known risk factor for cataract formation .
The decline in CALB1 expression is not due to reduced lens cell numbers but reflects genuine reduction in gene expression within cells .
This suggests CALB1 may be a critical factor in age-related lens changes and cataract development.
Neurological implications:
Reduced CALB1 expression is observed in several age-related diseases .
In neuronal populations, CALB1 reduction may contribute to calcium dysregulation and excitotoxicity associated with aging and neurodegenerative conditions .
CALB1 knockout alters expression of genes related to BDNF signaling and GABA signaling in the amygdala and prefrontal cortex, potentially affecting cognitive and emotional processing during aging .
Experimental approaches for studying age-related pathologies:
Longitudinal studies comparing CALB1 expression and pathology development across the lifespan .
Interventional studies manipulating CALB1 expression at different ages to determine critical periods for protection against pathology .
Combining CALB1 manipulation with environmental or pharmacological stressors that accelerate age-related pathologies.
Researchers investigating CALB1 in age-related pathologies should consider both preventive approaches (maintaining CALB1 expression) and therapeutic strategies (compensating for CALB1 reduction) in their experimental designs.
CALB1 appears to play an important neuroprotective role in rat models of brain injury, though the relationship is complex:
Protective mechanisms:
Pretreatment with PTD-calbindin D28k has been shown to alleviate rat brain injury induced by ischemia and reperfusion .
The neuroprotective effect likely involves CALB1's ability to buffer excessive intracellular calcium, which otherwise would trigger cell death cascades following injury .
CALB1 may also interact with downstream signaling pathways that promote cell survival and reduce inflammatory responses.
Stress and injury vulnerability:
Paradoxically, while CALB1 seems protective against direct neuronal injury, its expression in the ventral hippocampus contributes to stress susceptibility .
This suggests CALB1 may have different roles in acute physical brain injury versus psychological stress-induced changes.
The differential effects may depend on the specific brain regions, cell types, and injury mechanisms involved.
Experimental considerations for injury studies:
When designing rat models of brain injury to study CALB1's role, researchers should:
Compare acute versus chronic effects of CALB1 manipulation
Distinguish between preventive (pre-injury) and therapeutic (post-injury) CALB1 interventions
Assess multiple outcome measures including cellular survival, functional recovery, and behavioral outcomes
Consider region-specific CALB1 manipulation using targeted viral delivery methods
The relationship between CALB1 and neuroprotection highlights the importance of context-specific analyses in research design. The protein's protective effects may vary depending on the type of injury, timing of intervention, and specific neural circuits involved.
Calbindin-1 is a low molecular weight protein with a molecular weight of approximately 28 kDa. It contains six EF-hand motifs, each capable of binding a calcium ion. This protein acts as an intracellular calcium buffer, regulating the concentration of free calcium ions within the cytoplasm. By binding to calcium ions, Calbindin-1 helps to modulate various cellular processes, including neurotransmitter release, enzyme activity, and gene expression.
In the CNS, Calbindin-1 is expressed in discrete neuronal populations. It is highly abundant in Purkinje cells of the cerebellum, where it plays a critical role in motor coordination and synaptic plasticity . Additionally, Calbindin-1 is found in other brain regions, including the hippocampus, thalamus, and certain cortical areas. Its expression is developmentally regulated, with higher levels observed during periods of neuronal differentiation and migration .
Calbindin-1 is essential for maintaining calcium homeostasis in neurons. It acts as a calcium buffer, preventing excessive calcium fluctuations that could lead to cellular damage. This protein also participates in calcium signaling pathways, influencing processes such as synaptic transmission and plasticity. In Purkinje cells, Calbindin-1 is involved in long-term depression (LTD), a form of synaptic plasticity critical for motor learning .
Recombinant Calbindin-1 (Rat) is produced using recombinant DNA technology, allowing for the expression and purification of the protein in a controlled laboratory setting. This recombinant form is used in various research applications, including studies on calcium signaling, neurobiology, and protein-protein interactions. The availability of recombinant Calbindin-1 enables researchers to investigate its biochemical properties and functional roles in greater detail.
Calbindin-1 is widely used as a marker for specific neuronal populations in immunohistochemistry and immunofluorescence studies. Its expression pattern helps to identify and characterize different types of neurons within the CNS. Additionally, Calbindin-1 is utilized in studies exploring the mechanisms of calcium signaling and its impact on neuronal function and plasticity .